Lastest Videos.

31 October 2019 By Adam Butler

What Markets will Prime Gene Editing Revolutionise?

Reported to correct 89% of pathogenic human gene variants, prime gene editing has the potential to target over 75,000 different mutations in treatment. 

22 October 2019 By Lucy Smith

Is a Move to Connectivity the Next Big Step for Labs?

Our specialist in lab equipment and technology, Lucy Smith, is looking to get in touch with senior leaders in the life science space to learn more about connectivity.

08 October 2019 By George Coe

To PhD or Not to PhD?

I’ve lost count of the times I’ve seen ‘PhD preferred’, while recruiting for positions in R&D and product development. In the modern life science talent market, are PhDs really so important?

23 September 2019 By Adam Butler

Michael Schumacher, Stem Cell Therapy's Most High-Profile Case

Our Principal Consultant, Adam Butler, talks about the miracles of Stem Cell therapy, the issues surrounding it and the most high-profile case in the treatments' existence.

05 September 2019 By Jack Shute

The Future of Specialty Chemicals.

In an industry as fast paced as the specialty chemicals sector, it's almost impossible to predict the future, but we wanted to try.

02 September 2019 By Jack Shute

What's Trending in Specialty Chemicals Now?

Identifying the next big trend in a market like specialty chemicals can be gold dust for any company or individual savvy enough to see it.

19 August 2019 By Jack Shute

What is the Point in Conferences?

In today's hyper-connected world, what's the point of conferences? Our Associate Director Jack Shute asked experts from across the speciality chemical space and some of his CM Life Science colleagues to find out.

05 August 2019 By Adam Bakali

Meeting Mologic for a Lesson in Lateral Flow.

Lessons in lateral flow don't come much better than from a founding father of the technology. That's just what we got by speaking with Paul Davis, Co-founder and Chief Scientific Officer at Mologic.

Get the latest into your inbox.